Skip to main content

Press shift tab to select search category

Loading...

Download the report
A conversation with David Loew

Press shift tab to select search category

Loading...
English EN Français FR EN
- English EN
- Français FR
Annual Report
< Back
- Global EN FR
- Annual Report EN FR
United States

Brazil

Canada

Mexico

Australia

China

Singapore

South Korea

Japan

Belgium

Ukraine

UK

Germany

France

Nordics

Greece

Italy

Netherlands

Spain

Poland

Russia

Czech Republic

Switzerland

Austria

UAE & Gulf

Saudi Arabia

Study Indication: Advanced Or Metastatic Hepatocellular Cancer

A Study With Tasquinimod Treating Patients With Hepatocellular, Ovarian, Renal Cell and Gastric Cancers

IPN price

€170.80

€8.10 (4.98%)

Download the report
Ipsen.com
Contact us

Terms and Conditions
Cookie Policy
Global Privacy Policy

© Ipsen Pharma. All rights reserved - 2026

You are now leaving the Ipsen group global website. To continue, please click on Continue?